Pedro Ernesto Hospital Universitary
Rio de Janeiro, Brazil
NCT Number: NCT01861171
The purpose of this study is to evaluate the effects of green tea on body weight, waist circumference, metabolic profile, inflammation, blood pressure and endothelial function in obese pre-hypertensive women.
Looking for future studies?
Notify Me28 year–59 year
All sexes
Interventional
Not applicable
Rio de Janeiro, Brazil
Crossover randomized controlled double-blinded trial. Twenty women with obesity and pre-hypertension, aged 28-59 years, with stable body weight were randomized to receive a daily supplement of 3 capsules that contained either 500mg of green tea extract (GTE) or a matching placebo for 4 weeks, with a washout period of 2 weeks between the treatments. Endothelial function was evaluated by peripheral arterial tonometry method, using Endo-PAT 2000®.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
pre-hypertensive women obese adult
Exclusion criteria
pregnant smoker elderly
Twenty women with obesity and pre-hypertension, aged 28-59 years, with stable body weight were randomized to receive a daily supplement of 3 capsules that contained either 500mg of green tea extract (GTE) or a matching placebo for 4 weeks, with a washout period of 2 weeks between the treatments.
Time frame: 12 weeks
Rio de Janeiro State University
Other
Effect of Green Tea on Adiposity, Metabolic Profile, Blood Pressure and Endothelial Function in Obese Pre-hypertensive Women
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05061173
Body Weight, Cardiovascular Diseases
Kotli, Azad Jamu Kashmir, Pakistan
View Trial DetailsNCT01684748
Body Weight, Cardiovascular Diseases
View Trial DetailsNCT03857191
Apnea, Body Weight
Grenoble, France
View Trial DetailsNCT03907384
Body Weight, Cardiovascular Diseases
Omaha, Nebraska, United States
View Trial Details